Multiple Sclerosis Severity Score
Top Cited Papers
- 12 April 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (7) , 1144-1151
- https://doi.org/10.1212/01.wnl.0000156155.19270.f8
Abstract
Background: There is no consensus method for determining progression of disability in patients with multiple sclerosis (MS) when each patient has had only a single assessment in the course of the disease. Methods: Using data from two large longitudinal databases, the authors tested whether cross-sectional disability assessments are representative of disease severity as a whole. An algorithm, the Multiple Sclerosis Severity Score (MSSS), which relates scores on the Expanded Disability Status Scale (EDSS) to the distribution of disability in patients with comparable disease durations, was devised and then applied to a collection of 9,892 patients from 11 countries to create the Global MSSS. In order to compare different methods of detecting such effects the authors simulated the effects of a genetic factor on disability. Results: Cross-sectional EDSS measurements made after the first year were representative of overall disease severity. The MSSS was more powerful than the other methods the authors tested for detecting different rates of disease progression. Conclusion: The Multiple Sclerosis Severity Score (MSSS) is a powerful method for comparing disease progression using single assessment data. The Global MSSS can be used as a reference table for future disability comparisons. While useful for comparing groups of patients, disease fluctuation precludes its use as a predictor of future disability in an individual.Keywords
This publication has 12 references indexed in Scilit:
- A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibilityBrain, 2002
- Age‐related disability in multiple sclerosisAnnals of Neurology, 2002
- Association of Polymorphisms in the Apolipoprotein E Region with Susceptibility to and Progression of Multiple SclerosisAmerican Journal of Human Genetics, 2002
- Identifying disease modifying genes in multiple sclerosisJournal of Neuroimmunology, 2002
- The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measureBrain, 2001
- Development of a multiple sclerosis functional composite as a clinical trial outcome measureBrain, 1999
- Stratified or Multicentre Analysis with Extended Mantel–Haenszel StatisticsBiometrical Journal, 1991
- THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDYBrain, 1989
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983